DUBLIN--(http://www.researchandmarkets.com/research/dvnlnd/global) has announced the addition of the "Global Osteoporosis Epidemiology and Patient Flow Analysis - 2012" report to their offering.)--Research and Markets (
“Global Osteoporosis Epidemiology and Patient Flow Analysis - 2012”
This report provides insights into Osteoporosis epidemiology, Osteoporosis diagnosed patients, and Osteoporosis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Osteoporosis derived from epidemiological analysis, percentage of patients diagnosed with Osteoporosis, and percentage of patients treated with Osteoporosis therapy.
The study helps executives estimate Osteoporosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Osteoporosis prevalence, Osteoporosis diagnosis rate, and Osteoporosis treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Osteoporosis: Disease Definition
- Osteoporosis Patient Flow
- Osteoporosis Prevalence
- Osteoporosis Diagnosed Patients
- Osteoporosis Treated Patients
For more information visit http://www.researchandmarkets.com/research/dvnlnd/global